News | March 11, 2023
Marksans Pharma announces USFDA approval for Famotidine Tablets
Marksans' OTC Famotidine Tablets USP are acid reducers
Marksans' OTC Famotidine Tablets USP are acid reducers
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Subscribe To Our Newsletter & Stay Updated
